Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial

This study tested progesterone for perimenopausal hot flush ± night sweat (vasomotor symptom, VMS) treatment. It was a double-blind, randomized trial of 300 mg oral micronized progesterone@bedtime versus placebo for 3-months (m) after a 1-m untreated baseline during 2012/1–2017/4. We randomized untr...

Descripción completa

Detalles Bibliográficos
Autores principales: Prior, Jerilynn C., Cameron, Andrea, Fung, Michelle, Hitchcock, Christine L., Janssen, Patricia, Lee, Terry, Singer, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241804/
https://www.ncbi.nlm.nih.gov/pubmed/37277418
http://dx.doi.org/10.1038/s41598-023-35826-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241804/
https://www.ncbi.nlm.nih.gov/pubmed/37277418
http://dx.doi.org/10.1038/s41598-023-35826-w

Ejemplares similares